PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of tropmedLink to Publisher's site
 
Am J Trop Med Hyg. 2017 July 12; 97(1): 3–5.
Published online 2017 June 5. doi:  10.4269/ajtmh.16-0302
PMCID: PMC5508885

Precisely Tracking Childhood Death

Abstract.

Little is known about the specific causes of neonatal and under-five childhood death in high-mortality geographic regions due to a lack of primary data and dependence on inaccurate tools, such as verbal autopsy. To meet the ambitious new Sustainable Development Goal 3.2 to eliminate preventable child mortality in every country, better approaches are needed to precisely determine specific causes of death so that prevention and treatment interventions can be strengthened and focused. Minimally invasive tissue sampling (MITS) is a technique that uses needle-based postmortem sampling, followed by advanced histopathology and microbiology to definitely determine cause of death. The Bill & Melinda Gates Foundation is supporting a new surveillance system called the Child Health and Mortality Prevention Surveillance network, which will determine cause of death using MITS in combination with other information, and yield cause-specific population-based mortality rates, eventually in up to 12–15 sites in sub-Saharan Africa and south Asia. However, the Gates Foundation funding alone is not enough. We call on governments, other funders, and international stakeholders to expand the use of pathology-based cause of death determination to provide the information needed to end preventable childhood mortality.

Although global childhood mortality has dropped by half since 1990, it remains unacceptable that in 2015, one of every 20 children dies before 5 years of age. As the rates have decreased, in association with improved vaccine coverage, better health-care access, and malaria control, the remaining deaths occur disproportionately among neonates, which now account for 40–45% of childhood deaths, and in countries in parts of Africa and south Asia, where childhood mortality rates approach one in every 10 children.14 Surviving the neonatal period is becoming increasingly important to guarantee child survival, as the proportion of under-five deaths occurring in this period will continue to increase in relation to global child mortality reductions. The causes of neonatal deaths are poorly understood; thus, few interventions have been fielded against them. Verbal autopsies, a primary basis for estimating causes of death, discriminate most syndromes poorly, particularly in the neonatal period, and cannot identify causal pathogens, casting doubt over estimates used to focus, strategize, and measure progress.5,6 In the highest mortality regions in sub-Saharan Africa and south Asia, even verbal autopsy data are largely unavailable. For example, Global Burden of Disease estimates for cause-specific childhood mortality in the Democratic Republic of the Congo are modeled from two verbal autopsy studies published in 1989 and 1993, and one household survey based on report from the head of household (not verbal autopsy), published in 2006.7 Continued reliance on such data, coupled with increasing sophistication of modeling methods used, risks creating a false sense of assuredness regarding what is known about the causes of childhood mortality.

The United Nations has recently adopted ambitious Sustainable Development Goals, including the “end of preventable deaths of newborns and children under 5 years of age” by 2030.8 To realistically achieve such goals, the global community cannot continue to rely on uncertain, unrepresentative, and untimely mortality data. Deliberately implemented, more rigorous surveillance is needed to provide accurate information on causes of death, based on pathology specimens from children who have died. The findings must then be shared as soon as possible with families, government agencies, and global stakeholders.6 A novel approach, minimally invasive tissue sampling (MITS), builds on postmortem needle biopsies of tissue that have been in occasional use for disease-specific surveillance and outbreak investigations for decades. Innovative approaches have yielded rapid recognition of MITS as a comprehensive tool to obtain postmortem samples in challenging settings, demonstrating agreement with complete diagnostic autopsy in some 70–90% of cases.9,10 Preliminary results of a research project to validate MITS against gold standard methods in Mozambique and Brazil have shown that MITS has high agreement with, and can reliably substitute for, full autopsy, particularly for infectious causes of death.11 Over the past 18 months, MITS has been performed in an array of countries including Bangladesh, Brazil, Kenya, Mozambique, and South Africa, and has been acceptable to families. A multicountry anthropological research study has found good theoretical acceptability and willingness to know cause of death in the community.12 A recently completed hospital-based postmortem investigation in Soweto conducted among 365 stillbirths from June 2015 to September 2015, identified Group B Streptococcus to be definitely associated with 5% of the stillbirths and possibly related to a further 15%. This novel finding has the potential to change national policy in management and intervention in pregnant women to reduce a previously unrecognized, but potentially preventable cause of stillbirth. (S. A. Madhi, personal communication).

To address the problems of validity, timeliness, and regional representation described above, the Bill & Melinda Gates Foundation is funding the Child Health and Mortality Prevention Surveillance (CHAMPS) network. Coordinated by Emory University in association with the International Association of National Public Health Institutes, U.S. Centers for Disease Control and Prevention, and the Public Health Informatics Institute of the Task Force for Global Health, CHAMPS aims to more definitively determine the causes of childhood mortality in the highest-mortality regions of sub-Saharan Africa and south Asia, eventually including 12–15 sites. Each site will determine the causes of childhood death using MITS, in combination with conducting verbal autopsies and medical record abstractions, within demographically defined populations, producing ongoing cause-specific childhood mortality rates. Comprehensive anthropological work will be conducted to promote community engagement and sensitization, to increase the likelihood that MITS is welcomed by the communities and health-care providers, as well as religious, cultural, and political leaders.13 Ministry of Health and/or National Public Health Institute staff at each CHAMPS site will be engaged in implementation, analyses, and reporting to maximize the utility of evidence derived from CHAMPS for public health policy decision-making and local laboratory and pathology capacity will be built and supported to enable long-term sustainability and expansion. Protocols will be standardized across sites, and data will be uploaded to cloud-based servers for rapid dissemination to host governments and global stakeholders, such as the United Nations Children's Emergency Fund, World Health Organization, The World Bank, and disease burden expert groups. CHAMPS will seek to integrate with existing surveillance by aligning protocols and combining data with complementary systems, such as Sample Registration Systems14 and health management information systems to provide a current, comprehensive, and statistically valid view of childhood mortality. Six sites have been selected, and the first MITS data began flowing in January 2017.

Although we advocate MITS whenever possible for cause of death determination, we recognize that verbal autopsy and medical certification will remain more widely used because they can be done with less training and inexpensively—when MITS and verbal autopsy/medical certification are combined, they can provide more precise and statistically valid estimates of causes of death across all geographies of a country.6,15 Indeed, the recently funded Countrywide Mortality Surveillance for Action initiative in Mozambique will measure mortality across the country using representative sampling with verbal autopsy that is supplemented by MITS-based cause of death data from the CHAMPS site in Manhiça, as well as selected additional MITS in other parts of the country. We hope that this system can serve as a model for sample registration system solutions to civil registration and vital statistics (CRVS) in response to the global call for development and strengthening of CRVS.16

No child should die of a preventable cause in the new millennium. Pathology-based surveillance offers the potential for more accurately tracking the causes of death, enabling policymakers to match this information with precision public health strategies, applying policies that are specific, impactful, and responsive to changing epidemiology.15 We hope that CHAMPS will kindle a wide-scale demand and multifaceted financial support for strengthening public health systems to identify and tackle substantive contributors to unacceptably high death rates. However, Gates Foundation funding alone will not be enough to enable these outcomes. We encourage expanded use of surveillance linked to pathology-based cause of death determination at local, national, and global levels to provide the information needed to end preventable childhood mortality.

REFERENCES

1. GBD 2015 Child Mortality Collaborators , 2016. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388: 1725–1774. [PMC free article] [PubMed]
2. World Health Organization , 2009. State of the World's Vaccines and Immunization, 3rd edition Geneva, Switzerland: World Health Organization.
3. You D, Hug L, Ejdemyr S, Idele P, Hogan D, Mathers C, Gerland P, New JR, Alkema L., 2015. Global, regional, and national levels and trends in under-5 mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Inter-agency Group for Child Mortality Estimation. Lancet 386: 2275–2286. [PubMed]
4. Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, Lawn JE, Cousens S, Mathers C, Black RE., 2016. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 388: 3027–3035. [PMC free article] [PubMed]
5. Murray CJL, Lozano R, Flaxman AD, Serina P, Phillips D, Stewart A, James SL, Vahdatpour A, Atkinson C, Freeman MK, Ohno SL, Black R, Ali SM, Baqui AH, Dandona L, Dantzer E, Darmstadt GL, Das V, Dhingra U, Dutta A, Fawzi W, Gómez S, Hernández B, Joshi R, Kalter HD, Kumar A, Kumar V, Lucero M, Mehta S, Neal B, Praveen D, Premji Z, Ramírez-Villalobos D, Remolador H, Riley I, Romero M, Said M, Sanvictores D, Sazawal S, Tallo V, Lopez AD., 2014. Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med 12: 5. [PMC free article] [PubMed]
6. Fligner CL, Murray J, Roberts DJ., 2011. Synergism of verbal autopsy and diagnostic pathology autopsy for improved accuracy of mortality data. Popul Health Metr 9: 25. [PMC free article] [PubMed]
7. Institute for Health Metrics and Evaluation , 2016. Causes of Death (COD) Data Visualization. Seattle, WA: Institute for Health Metrics and Evaluation, University of Washington.
8. United Nations , 2017. Sustainable Development Goals: 17 Goals to Transform Our World. Available at: http://www.un.org/sustainabledevelopment/. Accessed February 7, 2017.
9. Maixenchs M, Anselmo R, Zielinski-Gutiérrez E, Odhiambo FO, Akello C, Ondire M, Zaidi SSH, Soofi SB, Bhutta ZA, Diarra K, Djitèye M, Dembélé R, Sow S, Minsoko PCA, Agnandji ST, Lell B, Ismail MR, Carrilho C, Ordi J, Menéndez C, Bassat Q, Munguambe K., 2016. Willingness to know the cause of death and hypothetical acceptability of the minimally invasive autopsy in six diverse African and Asian settings: a mixed methods socio-behavioural study. PLoS Med 13: e1002172. [PMC free article] [PubMed]
10. Blokker BM, Wagensveld IM, Weustink AC, Oosterhuis JW, Hunink MGM., 2015. Non-invasive or minimally invasive autopsy compared to conventional autopsy of suspected natural deaths in adults: a systematic review. Eur Radiol 26: 1159–1179. [PMC free article] [PubMed]
11. Castillo P, Martínez MJ, Ussene E, Jordao D, Lovane L, Ismail MR, Carrilho C, Lorenzoni C, Fernandes F, Bene R, Palhares A, Ferreira L, Lacerda M, Mandomando I, Vila J, Hurtado JC, Munguambe K, Maixenchs M, Sanz A, Quintó L, Macete E, Alonso P, Bassat Q, Menéndez C, Ordi J., 2016. Validity of a minimally invasive autopsy for cause of death determination in adults in Mozambique: an observational study. PLoS Med 13: e1002171. [PMC free article] [PubMed]
12. Munguambe K., 2015. Feasibility and Acceptability of Procedures to Determine Cause of Death: Preliminary Results from the CaDMIA Multicentre Study. The 9th European Congress on Tropical Medicine and International Health, September 6–10, 2015, Basel, Switzerland.
13. Bassat Q, Ordi J, Vila J, Ismail MR, Carrilho C, Lacerda M, Munguambe K, Odhiambo F, Lell B, Sow S, Bhutta ZA, Rabinovich NR, Alonso PL, Menéndez C., 2013. Development of a post-mortem procedure to reduce the uncertainty regarding causes of death in developing countries. Lancet Glob Health 1: 125–126. [PubMed]
14. Jha P, Gajalakshmi V, Gupta PC, Kumar R, Mony P, Dhingra N, Peto R., 2006. Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med 3: e18. [PubMed]
15. Dowell SF, Blazes D, Desmond-Hellmann S., 2016. Four steps to precision public health. Nature 540: 189–191.
16. AbouZahr C, de Savigny D, Mikkelsen L, Setel PW, Lozano R, Lopez AD., 2015. Towards universal civil registration and vital statistics systems: the time is now. Lancet 386: 1407–1418. [PubMed]

Articles from The American Journal of Tropical Medicine and Hygiene are provided here courtesy of The American Society of Tropical Medicine and Hygiene